BFRI
Biofrontera·NASDAQ
--
--(--)
--
--(--)
3.28 / 10
Netural
Fund flow metrics score 6.56/10, revealing robust fund flow characteristics. Beneficial Small and Medium trends are challenged by problematic overall, block, Large, and Extra-large signals, indicating positive capital movement. Analyst coverage indicates overwhelmingly bullish analyst consensus with strong conviction. Rating distribution: Strong Buy(100.0%) among 1 analysts, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Bruce JacksonStrong Buy
Date2025-05-19
InstitutionBenchmark
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for BFRI?
- BFRI holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.28/10 (Netural).
